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Abstract
Background: The quality of life of chronically ill individuals, such as hay fever sufferers, is significantly dependent
on their health behavior. This survey aimed to explain the health-related behavior of allergic individuals using the
protection motivation theory (PMT) and the transtheoretical model (TTM).
Methods: The influencing variables stated by PMT were operationalized based on data from semistructured pilot
interviews and a pretest with 12 individuals from the target population. The final questionnaire inquired perceived
seriousness and severity of hay fever, response efficacy, response costs, self-efficacy, and the use of various hay
fever management measures in relation to the TTM stages. Multivariate logistic regression was performed to
investigate the relationships between the PMT constructs and the examined health behavior.
Results: A total of 569 allergic individuals completed the online questionnaire. Only 33.26% of allergic individuals
were in the maintenance stage for treatment under medical supervision, and almost 60% preferred hay fever self-
management. A total of 67.56% had a well-established habit of taking anti-allergic medication, but only 25.31% had
undergone specific immunotherapy. The likelihood of seeking medical supervision was positively influenced by
perceived severity (OR = 1.35, 95% CI: 1.02–1.81), perceived seriousness (OR = 2.12, 95% CI: 1.56–2.89), and self-
efficacy (OR = 4.52, 95% CI: 3.11–6.65). The perceived severity of symptoms predicted the practice of hay fever self-
management (OR = 1.60, 95% CI: 1.21–2.11), as well as anti-allergic medication intake (OR = 1.65, 95% CI: 1.16–2.35).
The latter measure was also positively influenced by self-efficacy (OR = 1.52, 95% CI: 1.01–2.28) and hay fever self-
management (OR = 4.76, 95% CI: 2.67–7.49). Undergoing specific immunotherapy was significantly predicted only
by medical supervision (OR = 9.80, 95% CI: 8.16–13.80). Allergen avoidance was a strategy used by allergic
individuals who preferred hay fever self-management (OR = 2.56, 95% CI: 1.87–3.52) and experienced notable
symptom severity (OR = 2.12, 95% CI: 1.60–2.81).
Conclusion: Educational interventions that increase the awareness of health risks associated with inadequate hay
fever management and measures to increase self-efficacy might be beneficial for the promotion of appropriate hay
fever management among allergic individuals.
Keywords: Hay fever management, Utilization of health measures, Protection motivation theory, Transtheoretical
model, Threat appraisal
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Background
Quality of health and quality of life are essentially
dependent on an individual’s lifestyle and health habits.
By managing their health behavior, individuals can
significantly improve their well-being and live longer
and healthier lives. This consideration is especially
important for individuals suffering from chronic health
conditions, which significantly influence their health-
related quality of life. Allergic rhinitis, also called hay
fever, is considered by the World Allergy Organization
to be one of the most prevalent chronic diseases of the
respiratory tract [1]. In Europe, the prevalence of hay
fever stagnates on a high level ranging from 13 to 25%
among industrialized countries [2] and continues to
grow in its prevalence and severity [3], especially in
children [4]. Hay fever, as a chronic disease, impairs the
everyday activities, sleep quality, and workplace product-
ivity of its sufferers [5, 6] and lowers their perceived
quality of life [7–10]. Hay fever sufferers have several
options to control the severity of allergic symptoms,
such as the intake of antihistamines, specific immuno-
therapy, or allergen avoidance [11]. Despite the benefits
of allergy management through such practices, approxi-
mately 70% of hay fever sufferers do not treat their
disease properly [12] or fail to meet current allergy
management recommendations. Nevertheless, one of
four allergic individuals undergoes no treatment despite
having symptoms [13]. Therefore, the question of how
hay fever sufferers can be motivated to manage their
disease remains a crucial research direction.
The scientific community has mostly focused on the
supply side of the problem of hay fever and the develop-
ment of new medications and therapies to be offered to
disease sufferers. However, it is reasonable to examine the
other side of the problem and shift the research focus on
the demand side [14]. This approach can help to promote
effective self-management and health habits that keep
people healthy across their lifespan. In general, theories and
models help predict and explain health behavior in various
health-related contexts [15, 16]. Theories and models of
health behavior can be classified as motivational, behavioral
inaction, and multistage behavior change [17]. Motivational
theories propose continuous models to predict health
behavior at a single point in time or identify the influencing
factors of health-related behavior. Behavioral inaction
theories are intended to close the gap between motiv-
ation and actual behavior. Multistage models assume
that individual progress through various stages in the
execution of the desired behavior that ranges from the
intention to engage in the target behavior to the main-
tenance of the target behavior [18]. Multistage models
highlight the dynamic nature of behavior change based
on the assumption that individuals at different stages
think and behave in qualitatively different ways [19].
Protection motivation theory (PMT) is a prominent
example of a motivational theory of health behavior first
described by Rogers in 1975 [20]. There is a large body
of research that has used PMT to explain health behav-
ior in different health-related contexts, including self-
reported adherence to corticosteroid medication among
asthma patients [21], self-reported adherence to weight
loss recommendations [22], self-reported adherence to
therapy among people with coronary heart disease [23],
the promotion of exercise and healthy dietary behavior
[24], and nonpharmaceutical protective behavior during
influenza outbreaks [25]. Stage-based approaches to
behavior change, such as the transtheoretical model
(TTM), have received widespread scientific approval.
There is a large body of research that has applied the
TTM in a variety of health behavior contexts, including
asthma self-management [26], physical activity [27],
obesity prevention [28], sun protection [29], and smok-
ing cessation [30].
The main research objective of the present study was
to explain the health-related behavior of hay fever
sufferers based on protection motivation theory, as this
theory was considered to be the most suitable for the
specific features of hay fever. The stages of behavior
change outlined in the TTM were employed in this
study to provide a more detailed and comprehensive
differentiation of actors and nonactors regarding the use
of different allergy management measures among aller-
gic individuals. To our knowledge, neither the PMT nor
the TTM has been used in previous research to assess
the behavior of allergic individuals regarding their hay
fever management. The influencing variables corre-
sponding to the PMT constructs were expected to ex-
plain the motivation of allergic individuals to undertake
or forego particular health-related measures. Therefore,
the research question examined in the present survey
was formulated as follows:
How do the PMT constructs influence the utilization
of different hay fever management measures among
allergic individuals?
Methods
Operationalization of the PMT constructs
The operationalization of the PMT constructs was car-
ried out in two stages: pilot semistructured interviews
and a pretest with a sample of 12 individuals from the
target population. The participants in the preliminary
analysis were recruited from a pool of allergic individuals
who had participated in our previous research [12]. The
interviews aimed to identify the participants’ salient per-
ceptions of the health threat caused by hay fever as well
as the perceived reasonability and efficacy of the possible
health-related measures aimed at reducing allergic
symptoms. The main objective of the pretest using draft
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versions of the PMT scales was to test respondents’
comprehension of the scales and determine appropriate
wording for the statements.
The interviews consisted of open-ended questions
regarding the PMT constructs and closed-ended ques-
tions regarding the utilization of various hay fever
management measures. Each recruited allergic individual
completed a semistructured interview covering topics
presented in the following section.
Threat appraisal
According to PMT, protection motivation results from
an evaluation process consisting of threat appraisal and
response appraisal. The appraisal of the threat posed by
a disease consists of two major components: perceived
symptom severity and perceived vulnerability, i.e., the
likelihood of the occurrence of the disease [18]. Per-
ceived vulnerability was operationalized as perceived
seriousness of hay fever since allergic individuals already
had the disease of interest, and thus, it would not be
relevant for them to appraise their likelihood of getting
hay fever. There are some interesting insights in our
previous research suggesting a crucial impact of the
perceived seriousness of hay fever on its management
[12], making this adaptation reasonable. Along with the
study of Bennett et al. (1998) investigating adherence to
preventive asthma medication, in the present study the
perceived seriousness of hay fever was inquired as the
perceived chronicity of hay fever [21]. Also, the
inquiries of threat appraisal focused on the perceived
need for hay fever treatment and its advantages and
disadvantages. The perceived severity of hay fever was
assessed based on the negative effects of allergic symp-
toms on various dimensions of everyday life, with a focus
on social functioning, school or workplace productivity,
and quality of sleep when symptomatic.
Response appraisal
Response appraisal describes the assessment of the
efficacy or value of certain health behavior in reducing
the threat caused by a disease and consists of three
components: response efficacy, response costs, and self-effi-
cacy. Response efficacy measures the expected benefit of the
target behavior in preventing the disease or its harmful in-
fluence on health-related well-being. Response costs com-
prise the expected physical, psychological, financial, and
other efforts involved in the target behavior. Self-effi-
cacy describes the extent to which an individual feels
capable of performing the target behavior [18]. To initi-
ate a particular health behavior, the utility of response
efficacy and self-efficacy has to outweigh the response
costs of the target behavior [16].
Response efficacy was operationalized as the perceived
or possible positive effects of known hay fever measures
on health-related well-being when symptomatic. The
open-ended questions concerning response efficacy were
designed to address the dimensions that allergic individ-
uals mentioned being negatively affected by allergic symp-
toms in the previous part of the interview. Response costs
were estimated as the barriers preventing allergic individ-
uals from taking action or the inconvenience arising from
the need to take hay fever management measures consist-
ently and regularly. Self-efficacy was assessed by questions
regarding the individual’s perceived ability to positively in-
fluence his or her well-being when symptomatic. Another
dimension of self-efficacy was the individual’s perceived
capability of carrying out health-related measures regu-
larly and consistently.
Pretest
Following the interviews, draft versions of the PMT scale
were administered to the recruited interviewees. We
developed the scales based on an extensive literature
review [21, 23, 25, 31, 32], and our previous study inves-
tigating health-related impairment caused by allergic
symptoms and salient beliefs regarding allergy manage-
ment [12]. All items assessing the PMT constructs were
drafted as closed-ended questions consisting of belief
statements followed by a five-point Likert scale (1 = totally
disagree, 2 = somewhat disagree, 3 = neutral, 4 = somewhat
agree, 5 = totally agree). Allergic individuals were asked to
assess the applicability of the statements to themselves.
Furthermore, we have encouraged study participants to
give general feedback on the questionnaire and to indicate
items that were not clearly formulated or were difficult to
understand.
Based on the insights obtained in the interviews,
additional items with belief statements that had not been
previously considered were added to the original drafts of
the PMT scales. The less important beliefs corresponding
to each PMT component were excluded from the final
questionnaire. Additionally, the wording of some items
was changed to be more explicit and easy to understand.
The semistructured interview guide and the final ques-
tionnaire can be found in supplementary materials.
Operationalization of the allergy management across the
TTM stages
Allergy management was assessed with five items specify-
ing five possible allergy management measures: treatment
under medical supervision, hay fever self-management,
anti-allergic medication, specific immunotherapy, and al-
lergen avoidance. The respondents were asked to indicate
their current stage in the utilization of each hay fever
management measure. The possible answers to the state-
ments, e.g. “I take anti-allergic medication” were “no, and
I do not intend to” (pre-contemplation); “no, but I might
think about it” (contemplation); “no, but I strongly intend
Muzalyova and Brunner BMC Public Health         (2020) 20:1876 Page 3 of 12
to do so” (preparation); “yes, but I only started doing it
recently” (action); and “yes, and I have been doing it for a
long time” (maintenance). Therefore, the use of the TTM
allowed us to evaluate both intention and action regarding
the target behavior.
Based on the insights from the pretest and pilot interviews
the final questionnaire consisted of 33 items related to the
PMT constructs, five items on hay fever management, and
several items inquiring about the allergy characteristics of
survey participants.
Participants and procedure
This cross-sectional study was conducted between the
9th and 30th of September 2019 using an online survey
tool. The start date of the study was intentionally chosen
to avoid high pollen load and thus to increase the likeli-
hood of study participants being asymptomatic at the
time of the study. The study target group was defined as
hay fever sufferers who are sensitized exclusively to air-
borne pollen. Consequently, only participants who were
allergic to airborne pollen and did not have additional
perennial allergies to dust mites or animal dander were
included in the study. All study participants who did not
meet the defined inclusion criteria were excluded from
the data analysis. The inclusion of the participants in the
study was based on self-reported information on pollen
sensitization.
The questionnaires were distributed to all participants
who were recruited during the previous study conducted
in June and July 2016 to collect data on the health
behavior of hay fever sufferers. Additionally, we invited
all matriculated students of the University of Augsburg
as well as all university personnel who were allergic to
airborne pollen to participate in the present survey. A
total of 805 invited allergic individuals accessed the
online questionnaire, and 569 (70.7%) completed it.
Eight study participants were excluded since they did
not fulfill the inclusion criteria due to an additional
sensitization to dust mites (n = 7) or animal dander (n =
1). Consequently, the remaining 561 participants were
found eligible, and their responses were used for data
analysis.
The calculation of the minimal sample size was carried out
based on Riley et al. (2019). Anticipating a Van Houwelingen
shrinkage factor of 0.90, and adjusted Cox-Snell R2 of 0.18
with up to 11 parameters to be estimated, the minimum
sample size accounts for 494 participants [33]. Therefore, the
sample size of 561 participants is appropriate for the given
research setting.
Data analysis
The survey results were analyzed using SPSS 25 (Statis-
tical Package for the Social Sciences; SPSS Inc., Chicago,
IL, USA) and AMOS SPSS 25. The majority of eligible
study participants (85.56%, n = 480) answered all items,
and no item had more than 3.21% (n = 18) missing
values. The missing values for the items on PMT com-
ponents were imputed using SPSS MVA regression with
gender, allergy characteristics, and responses to the
complete PMT subscale items as predictors. In line with
the multiple imputation routines, a total of m= 50 dif-
ferent datasets were imputed to assure the appropriate
statistical power of the inferencestatistical analysis of the
data [34].
Construct validity of the developed measurement
instrument was evaluated through explanatory factor
analysis using oblimin rotation. The number of under-
lying factors was determined using parallel analysis [35].
For all inquired latent variables, reliability in terms of
Cronbach’s alpha, composite reliability (CR), and average
variance extracted (AVE) were examined to assure the
appropriateness of the measurement model. The overall
fit of the proposed measurement model was evaluated
using a confirmatory factor. In the present study χ2/df
ratio, Tucker-Lewis index (TLI), Comparative Fit Index
(CFI), and Root Mean Square Error of Approximation
(RMSEA) are reported. The χ2/df ratio of less than 2.0,
TLI and CFI greater than 0.9, and RMSEA < 0.10 are
considered to indicate an appropriate model fit [36].
The measurement scales for each PMT construct were
averaged across the items to be used in the logistic re-
gression as independent variables. Frequencies were used
to describe the utilization rates of different hay fever
management measures. Multivariate logistic regression
was performed to investigate the relationships between
the PMT constructs used as independent variables and
the aggregated TTM stage variables used as dependent
variables. Additionally, the TTM stage variables were
stepwise imputed in the model as independent variables
to investigate their interdependencies. Statistical signifi-
cance was considered at the 0.95 level (p < 0.05). To address
the current criticism of frequentist methods and p-values
specifically, we used multiple tests. Consequently, all p-
values given in this paper were adjusted for multiplicity
using the Benjamini-Yekutieli step-up procedure [37].
Results
Descriptive results
Females constituted 61.85% (n = 347) of the total study
sample. The study participants had exhibited allergic
symptoms for 14.59 (SD = 9.80) years. Information on
the use of various hay fever management measures is
outlined in Table 1. Only 33.16% (n = 186) of the study
sample was in the maintenance stage for allergy treat-
ment under medical supervision, whereas almost 60 %
(n = 333) were in the maintenance stage for allergy self-
management. Approximately 30 % (n = 171) claimed that
they were not being treated under medical supervision
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and that they did not intend to do so (pre-contemplation
stage). Those who had a well-established habit of taking
anti-allergic medication accounted for 67.56% (n = 379).
Only 25.31% (n = 142) of all individuals were in the
maintenance stage of specific immunotherapy, but an-
other 4.81% (n = 27) were in the action stage, having
started it recently. A total of 27.09% (n = 152) of the
survey participants stated that they were thinking about
the possibility of utilizing specific immunotherapy but
were not currently undergoing it (contemplation stage).
Almost half (n = 277) of all participants were in the
maintenance stage for allergen avoidance measures,
whereas approximately one-fifth had completely stopped
practicing this allergy management measure.
Due to a small size resulting in a small number of survey
participants at the contemplation and preparation stages,
the TTM stage variables were aggregated as dichotomous,
categorical variables to differentiate between early-stage
and late-stage of action regarding five examined allergy
management measures. Following Prochaska et al. (1992),
the early-stage included pre-contemplation, contempla-
tion, and preparation stages of behavior change, and the
late-stage included action and maintenance [38]. There-
fore, participants in the early stages were not utilizing
particular hay fever management measures, including
those reporting total resignation, contemplation, or
intention of a target behavior. Participants in the late
stages included allergic individuals who had utilized
particular hay fever management measures recently or for
a longer time. Consequently, study participants in the two
categories can be referred to as nonactors and actors.
Assessment of the measurement model
In the first stage of the data analysis, the reliability and
validity of the constructed PMT scales were assessed.
The parallel analysis has determined six factors explain-
ing 52.379% of the total variance to be extracted
(Table 2).
The items forming each factor were identified after
oblimin rotation was applied. Analysis of the rotated
factor matrix reported in Table 3 showed that the latent
construct self-efficacy consisted of 2 underlying subcon-
structs. To maintain the unidimensionality of the self-ef-
ficacy scale, the items forming the factor with lower
eigenvalues and the proportion of explained variance
were excluded from the further analysis. Additionally,
three items of the latent construct seriousness were
excluded due to their low factor loadings. Furthermore,
one item each of the response efficacy and self-efficacy
scales was omitted due to low factor loading, and one
item of the response costs scale was excluded due to a
cross-loading on the response efficacy scale. Conse-
quently, the final measurement model consisted of 22
items reflecting five PMT variables. The Cronbach’s
alpha (Table 3) of the examined PMT scales was above
the value of 0.7 indicating appropriate reliability for all
latent constructs, and the CR and AVE of each scale
were above the recommended values of 0.7 and 0.5,
respectively [39]. Overall, the presented results allow the
conclusion that all captured latent constructs have the
appropriate reliability and convergent validity.
The discriminant validity of the measurement model
was assessed by a visual examination of the matrix of
Table 1 Utilization of different allergy management measures expressed as TTM stages (in %)
Early-stage (not taking action) Late-stage (taking action)
Pre-contemplation Contemplation Preparation Σ Action Maintenance Σ
Medical supervision 30.48 22.82 6.42 59.72 7.13 33.15 40.28
Self-management 18.18 7.49 2.50 28.17 12.48 59.35 71.83
Anti-allergic medication 10.70 7.13 1.43 19.26 13.19 67.55 80.74
Specific immunotherapy 37.62 27.09 5.17 69.88 4.81 25.31 30.12
Allergen avoidance 21.21 11.41 4.28 36.90 13.73 49.37 63.10
Table 2 Results of the parallel analysis
Parallel analysis Explorative factor analysis
Factor Means Percentile Eigenvalue Explained variance (%) Cumulated variance (%)
1 1.485 1.534 5.979 18.119 18.119
2 1.422 1.459 4.876 14.776 32.895
3 1.373 1.411 2.153 6.526 39.420
4 1.336 1.370 1.593 4.829 44.249
5 1.296 1.332 1.369 4.148 48.397
6 1.266 1.291 1.314 3.982 52.379
7 1.235 1.258 1.112 3.371 55.751
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Table 3 Rotated factor loading matrix (oblimin rotation)
Factors
1 2 3 4 5 6
Seriousness
Cronbach’s Alpha = 0.709, CR = 0.756, AVE = 0.509, Mean (SD) = 3.53(0.786)
Hay fever is a disease 0.179 − 0.0180 0.116 0.751 − 0.022 0.012
Hay fever is a chronic health condition [Ex] 0.208 0.055 0.213 0.591 −0.073 0.180
Hay fever is a serious health condition 0.421 0.132 0.116 0.649 − 0.064 0.183
Hay fever is a health condition that has to be treated [Ex] 0.355 0.208 0.023 0.537 0.030 0.358
I see my hay fever as a long-term health condition 0.389 0.099 0.142 0.736 0.011 0.007
Hay fever influences an individual’s well-being [Ex] 0.198 0.176 −0.007 0.344 −0.041 0.006
Severity
Cronbach’s Alpha = 0.866, CR = 0.900, AVE = 0.600, Mean (SD) = 3.62(0.848)
…I feel physically burdened 0.812 0.066 0.225 0.325 −0.089 0.070
…I feel limited in my social life 0.772 −0.018 0.256 0.387 −0.115 0.059
…I feel limited in my spare time 0.815 −0.011 0.217 0.335 −0.077 0.024
…my sleep quality is burdened 0.662 −0.014 0.233 0.262 −0.219 0.061
…my overall well-being is burdened 0.799 −0.006 0.146 0.304 −0.097 0.075
…I experience a loss of productivity 0.773 0.085 0.082 0.288 −0.051 0.066
Response efficacy
Cronbach’s Alpha = 0.817, CR = 0.856, AVE = 0.598, Mean (SD) = 3.91 (0.714)
…weakens symptom severity −0.032 0.752 −0.203 − 0.056 0.341 0.175
…helps better control allergic symptoms −0.034 0.774 −0.029 0.283 0.083 0.261
…helps manage everyday routines 0.052 0.762 −0.111 0.222 0.252 0.190
…improve overall well-being 0.017 0.804 −0.249 0.001 0.291 0.232
…helps staying productive during the pollen season [Ex] 0.041 0.553 −0.180 0.083 0.337 0.168
Response costs
Cronbach’s Alpha = 0.789, CR = 0.770, AVE = 0.527, Mean (SD) = 2.95(0.882)
…is time consuming 0.036 −0.016 0.739 0.150 −0.122 −0.030
…is impairing my everyday life 0.273 −0.274 0.769 0.101 −0.176 −0.172
…requires substantial financial effort 0.323 −0.101 0.553 0.167 −0.201 −0.076
…is annoying 0.172 −0.296 0.755 0.014 −0.105 −0.164
…is inconvenient 0.163 −0.215 0.788 0.143 −0.118 −0.209
…is not worth it [Ex] 0.167 −0.586 0.464 0.007 −0.433 −0.169
Self-efficacy
Cronbach’s Alpha = 0.715, CR = 0.800, AVE = 0.502, Mean (SD) = 3.27(0.694)
Overall, I am capable of undertaking allergy management measures −0.102 0.308 −0.030 0.017 0.727 0.245
If required, I am capable of taking allergy management measures
consistently
0.233 0.288 0.015 0.162 0.634 0.119
If required, I am capable of taking allergy management measures
regularly
−0.169 0.214 −0.214 − 0.139 0.807 0.144
If required, I am capable of taking allergy management measures
despite difficulties [Ex]
−0.229 0.457 −0.327 −0.140 0.629 0.087
I can affect my health-related well-being during the pollen season −0.231 0.202 −0.224 −0.047 0.653 0.016
My health-related well-being during the pollen season is dependent on
my health behavior [Ex]
0.099 0.217 −0.181 0.048 0.013 0.707
If I take care of my allergy management during the pollen season, I can
avoid severe allergic symptom [Ex]
0.025 0.276 −0.016 0.174 0.282 0.679
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loadings and cross-loadings of the latent constructs. As
shown in Table 3, the items load more on the latent
constructs they are supposed to load. Furthermore, the
square roots of AVE values for all constructs were larger
than the correlations with other constructs (Table 4).
Therefore, it can be concluded that the constructs show
appropriate discriminant validity.
Since the reliability and construct validity conditions
were met, the analysis continued with the confirmatory
factor analysis (CFA) to test the overall appropriateness
of the proposed measurement model. The CFA revealed
the χ2/df ratio of 1.99, which was slightly below the
recommended value of 2.0. The TLI and CFI were 0.917
and 0.934, respectively, representing an appropriate
model fit. The RMSE accounted for 0.052, also indicat-
ing an appropriate mode fit. Detailed information on the
results of the CFA can be found in the supplementary
materials. Consequently, the measurement model can be
used for inferencestatistical analysis.
Influencing factors of the utilization of allergy
management measures
The results of the average PMT scale scores are shown
in Table 3. The perceived seriousness of hay fever and
perceived severity accounted for 3.53 (SD = 0.786) and
3.62 (SD = 0.848), respectively. Both values were above
the mean of the scale, nevertheless, did not indicate
threat appraisal to be high. Regarding the response ap-
praisal, the average allergy management measures score
was 3.91 (SD = 0.714), indicating high perceived response
efficacy of allergy management measures. The score for the
response costs scale was 2.95 (SD = 0.882), indicating mod-
erate expected effort associated with allergy management.
Consequently, the benefits of hay fever management ap-
peared to outweigh the required efforts. Self-efficacy had a
score of 3.27 (SD = 0.694), indicating a moderate perceived
ability to perform the target behavior.
The correlation coefficients of the average PMT scale
scores are shown in Table 4. The perceived seriousness
of the disease was strongly correlated with the perceived
severity of allergic symptoms (ρ = 0.633). The perceived
severity was also moderately correlated with response
costs (ρ = 0.310), indicating a higher perceived effort
associated with higher symptom severity. The response
costs showed a moderate negative relationship with self-
efficacy (ρ = − 0.345) and response efficacy (ρ = − 0.397),
suggesting that perceptions of one’s own ability to per-
form the target behavior and perceptions of the efficacy
of allergy management decrease with increasing symp-
tom severity. Response efficacy was strongly correlated
with self-efficacy, suggesting that both constructs rein-
forced each other.
Factors influencing the utilization of various allergy
management measures are shown in Table 5. Three vari-
ables were found to exert a positive effect on the willing-
ness to manage hay fever under medical supervision, with
self-efficacy increasing the probability of treatment under
medical supervision almost 5-fold (OR = 4.52, 95% CI:
3.11–6.56). Perceived seriousness of hay fever had a slightly
stronger positive effect on treatment under medical super-
vision (OR = 2.12, 95% CI: 1.56–2.89) than perceived se-
verity of symptoms (OR = 1.35, 95% CI: 1.02–1.81).
Perceived symptom severity showed a significant posi-
tive effect on the decision to manage hay fever without
medical support, increasing its probability by 60% (OR =
1.60, 95% CI: 1.21–2.11). Females (OR = 1.44, 95% CI:
1.25–2.26) were significantly more likely to self-manage
their hay fever than men, but this finding was rejected
due to multiple testing. Participants who reported being
treated by a doctor were significantly less likely to per-
form additional self-management measures (OR = 0.39,
CI: 0.25–0.86). This finding suggests that allergic indi-
viduals opt for one of the two alternatives, either hay
fever self-management or hay fever treatment under
medical supervision. However, these groups are still not
completely distinct.
Table 3 Rotated factor loading matrix (oblimin rotation) (Continued)
Factors
1 2 3 4 5 6
Proper allergy management requires me to change my habits, which is
difficult for me [Ex] [R]
0.146 0.162 −0.043 0.181 0.140 0.664
My health-related well-being during the pollen season is dependent
exclusively on factors I cannot control [Ex][R]
−0.213 0.108 −0.472 −0.136 0.056 0.538
If required, I can overcome inconveniences and difficulties related to
allergy management during the pollen season [Ex]
−0.253 0.274 −0.320 −0.033 0.219 0.270
Note. [Ex] denotes items that were excluded from use in the scales due to their low factor loadings or cross-construct loadings. [R] indicates reverse coded items
Table 4 Correlations and square roots of average variance
extracted
(1) (2) (3) (4) (5)
(1) Seriousness 0.713
(2) Severity 0.633 0.775
(3) Response efficacy 0.184 0.025 0.773
(4) Response costs 0.148 0.310 −0.345 0.726
(5) Self-efficacy −0.136 −0.301 0.600 −0.397 0.709
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Self-efficacy (OR = 1.52, 95% CI: 1.01–2.28) and per-
ceived symptom severity (OR = 1.65, 95% CI: 1.16–2.35)
exerted positive effects on the decision to take anti-
allergic medication, with the latter construct being a
slightly stronger predictor. Hay fever management under
medical supervision and hay fever self-management had
even stronger impacts on the likelihood of taking anti-
allergic medication. Those receiving medical help were
twice as likely to take antihistamines (OR = 2.22, 95% CI:
1.48–3.35), whereas allergic individuals self-managing
their hay fever were 4.5 times more likely to utilize anti-
allergic medication (OR = 4.48, 95% CI: 2.67–7.49).
Only one variable predicted the decision to undergo
specific immunotherapy. Participants being treated by a
doctor were 10 times as likely to make use of this cura-
tive therapy option (OR = 9.80, 95% CI: 8.16–13.80).
Perceived symptom severity (OR = 2.12, 95% CI: 1.60–
2.81) and self-efficacy (OR = 1.46, 95% CI: 1.07–1.99)
increased the likelihood of allergen avoidance, whereas in-
creasing perceived seriousness of the disease was associated
with decreasing willingness to undertake avoidance strat-
egies (OR = 0.72, 95% CI: 0.54–0.96). However, the latter
finding was found to be nonsignificant after multiple test-
ing. Nevertheless, allergic individuals preferring hay fever
self-management were significantly less reluctant to make
use of allergen avoidance strategies (OR = 2.56, 95% CI:
1.87–3.52).
Discussion
The presented empirical investigation has revealed three
major findings and makes the following key contributions.
First, health-related decisions regarding the utilization of
various hay fever management measures were substan-
tially stronger motivated by threat appraisal than by
response appraisal. Second, the perceived severity of symp-
toms was the dominant driver of threat appraisal, which
facilitated health-related decisions. Third, self-efficacy
was the only significant influencing factor of response
appraisal affecting hay fever management decisions in
allergic individuals.
In the consideration of these survey results, it must be
noted that participation in this survey was voluntary,
and the online questionnaire was also distributed to all
students of the University of Augsburg. Thus, a large
proportion of the study participants were young, well-
educated allergic individuals. In this way, there is a cer-
tain degree of bias in the respondents’ answers, as the
study sample might represent a specific population.
However, young adults who are students exhibit a higher
prevalence of allergic sensitization than other age groups
[40]. The possible bias was minimized through thought-
ful and careful scale development based on interviews
and a pretest with a sample from the target population.
Furthermore, our analysis relied on participants’ self-
reported information concerning the utilization of differ-
ent hay fever management measures and suffering from
hay fever in general. The main limitation of the present
survey was the relatively small sample size, which did
not allow us to separately analyze the PMT influencing
variables for each TTM stage.
Considering the assessed TTM stages, for each hay fever
management measure, the largest share of participants
Table 5 Association between the PMT constructs and examined allergy management measures















Reference category (Yes a)
Seriousness 2.12 (1.56–2.89)** 1.04 (0.77–1.41) 0.95 (0.65–1.40) 1.13 (0.81–1.56) 0.72 (0.54–0.96)*†
Severity 1.35 (1.02–1.81)* 1.60 (1.21–2.11)** 1.65 (1.16–2.35)** 0.83 (0.61–1.13) 2.12 (1.60–2.81)**
Response efficacy 1.16 (0.83–1.62) 1.00 (0.73–1.38) 1.40 (0.96–2.06) 1.08 (0.78–1.58) 1.04 (0.77–1.42)
Response costs 1.34 (1.03–1.73) 0.88 (0.67–1.13) 1.09 (0.79–1.51) 1.25 (0.95–1.64) 1.28 (1.00–1.64)
Self-efficacy 4.52 (3.11–6.56)** 1.37 (0.99–1.90)* 1.52 (1.01–2.28)* 0.97 (0.67–1.32) 1.46 (1.07–1.99)*†
Allergy experience 1.00 (0.98–1.03) 1.02 (1.00–1.04) 1.04 (1.00–1.07)*† 1.00 (0.98–1.03) 1.01 (0.99–1.03)
Gender (female) 1.17 (0.79–1.63) 1.44 (1.25–2.26)*† 1.25 (0.96–2.17) 0.70 (0.45–1.11) 1.03 (0.81–1.69)
Medical supervision a 0.39 (0.25–0.86)** 2.22 (1.48–3.35)* 9.80 (8.16–13.80)** 0.66 (0.44–1.09)
Self-management a 4.76 (2.67–7.49)** 0.91 (0.59–1.51) 2.56 (1.87–3.52)**
Anti-allergic medication a 1.26 (0.66–2.40) 1.17 (0.67–1.87)
Specific immunotherapy a 1.09 (0.67–1.78)
*Significance level p < 0.05, ** Significance level p < 0.01, † not significant due to multiple testing, a Reference category “taking action”
Model 1: R2 = 0.29 (Cox & Snell), 0.37 (Nagelkerke), χ2 (7) 169.74, p < 0.00; Model 2: R2 = 0.25 (Cox & Snell), 0.33 (Nagelkerke), χ2 (8) 168.24, p < 0.00; Model 3: R2 =
0.47 (Cox & Snell), 0.62 (Nagelkerke), χ2 (9) 347.43, p < 0.00; Model 4: R2 = 0.37 (Cox & Snell), 0.49 (Nagelkerke), χ2 (10) 250.47, p < 0.00; Model 5: R2 = 0.21 (Cox &
Snell), 0.28 (Nagelkerke), χ2 (11) 121.75, p < 0.00
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was in either the pre-contemplation or maintenance stage.
This finding indicates that most allergic individuals either
had utilized an allergy management measure for a long
time or did not even intend to it. Considering that the
mean duration of allergies was almost 15 years, the
included allergic individuals might have developed well-
established habits concerning their approach to managing
hay fever, especially if their existing behavior was per-
ceived as reasonable and satisfactory. The only exception
was found regarding the utilization of specific immuno-
therapy, for which the group of nonactors was larger than
the group of actors. Furthermore, the largest portion of
allergic individuals in the maintenance stage was found
for the intake of anti-allergic medication, and the largest
proportion of allergic individuals in the pre-contemplation
stage was found for specific immunotherapy. The smallest
share of allergic individuals was in the preparation stage
across all questioned hay fever management measures ex-
cept for specific immunotherapy. This finding suggests
that individuals either quickly translate their intentions
into action or fall back into the contemplation stage. A
similar finding was reported by Schwarzer (1999), who
emphasized that holding a strong intention does not guar-
antee the initiation of action. People may fail to address
self-regulatory problems during behavior change due to
various obstacles, such as changes in the surrounding
context [41].
Three PMT constructs were shown to significantly
influence health-related decisions concerning hay fever
management. First, the perceived seriousness of hay fever
had a significant positive effect on the decision to seek
medical support and tended to be negatively related to
allergen avoidance strategies. Second, perceived hay
fever severity showed a significant positive effect on four
allergy management measures, including treatment
under medical supervision, allergy self-management,
intake of anti-allergic medication, and allergen avoidance.
Third, self-efficacy was found to be a significant predictor
for three health-related measures, namely, treatment
under medical supervision, intake of anti-allergic medica-
tion, and allergen avoidance. Additionally, self-efficacy
tended to be positively related to allergy self-management.
Interestingly, perceived self-efficacy had a substantially
stronger effect on the decision to treat allergy under med-
ical supervision than to practice allergy self-management.
Remarkably, neither response efficacy nor response costs
significantly influenced health-related decisions in hay
fever management.
From the insights presented above, two conclusions
can be drawn. First, since perceived symptom severity
positively influenced all except one investigated allergy
management measure, occurring allergic symptoms might
be considered a trigger that induces action for allergy
management. This conclusion is consistent with the
results of Meltzer et al. (2017), who showed hay fever
sufferers to consider the onset of allergic symptoms to be
a starting point for their medication [8]. Second, anti-
allergic measures are induced rather by threat appraisal
than response appraisal. This observation is in line with
the results of Ferrer and Klein (2015), who showed that
health-related risk perceptions appear to play a more im-
portant role in motivating behavior change than perceived
response efficacy [42]. Furthermore, this finding supports
the so-called early-effectiveness hypothesis, which sug-
gests the fear appeal to be more effective in prompting
people to change behavior because they initially need to
understand that a threat exists to develop motivation and
increase their commitment to adopt new behavior [43].
In addition to the influence of the PMT constructs,
several allergy management measures were significantly
related to each other. In particular, participants who
engaged in allergy self-management were more likely to
take anti-allergic medication, whereas allergic individuals
being supported by a doctor in hay fever management
were not. Two possible reasons might be responsible for
these findings. First, the intake of medicine is the most
obvious measure to address some health-related issues.
Second, hay fever sufferers can buy several over-the-
counter antihistamines without medical advice or prescrip-
tion, which makes this allergy management option popular
among hay fever sufferers [44, 45]. The use of specific
immunotherapy, as the only curative treatment option, was
significantly predicted only by medical supervision. On the
one hand, this finding is self-explanatory because specific
immunotherapy can be carried out exclusively under med-
ical supervision. On the other hand, it remains unclear why
none of the PMT constructs significantly influenced the de-
cision to undergo specific immunotherapy. We suggest that
allergic individuals seeking medical supervision completely
rely on doctors’ advice without considering further factors.
Positive, informed changes in health-related behavior
are a desirable endpoint for the problem of inadequate
allergy management. Educational interventions providing
general knowledge about diseases and possible self-
management strategies have been shown to have a bene-
ficial effect on behavioral change and health outcomes in
chronically ill individuals [46–48]. Vulnerable individuals
suffering from chronic health conditions are interested
in receiving information on protective behavior related
to their disease, especially regarding immediate-term
advice on health management [49]. Concrete advice on
health behavior during the pollen season might be bene-
ficial for hay fever sufferers since even general health
recommendations such as the importance of adequate
sleep duration and appropriate body weight might be rele-
vant to decrease the risk of suffering allergic symptoms
[50]. Based on the insights of the present study, health
education for allergic individuals should be focused on
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variables related to threat appraisal, especially on the
perceived seriousness of the disease. The manipulation
of threat appraisal variables was shown to significantly
change perceptions of disease and, consequently, the
health behavior of people concerned [51]. However, it
has to be taken into account that fear appeals have the
potential to promote maladaptive responses, such as
defensive psychological tactics to resist negative
messages [52]. Particularly, if the threat appraisal is
high and the possible response to threat is perceived
to be ineffective. Fear appeals accompanied by increas-
ing self-efficacy and response efficacy and decreasing
response costs appear to be more effective [53]. Infor-
mation on coping that is aimed at increasing perceived
response efficacy perceived self-efficacy is more effect-
ive in enhancing protective intention than health
information that only increases the perceived threat
[54]. Since all motivators are rooted in the core belief
that one has the power to achieve the desired change,
the second focus of health education should be on
increasing self-efficacy in allergic individuals. Indeed,
promoting more positive attitudes can facilitate behav-
ior change by increasing self-efficacy for healthier
behavior [55].
Conclusion
According to the insights offered by this study, a large
share of allergic individuals do not engage in allergy
management under medical supervision and tend to
treat themselves self-reliantly. Since a large share of
allergic individuals uses over-the-counter medication,
obtaining first-line advice from a pharmacist might be
considered a valuable alternative to medical supervision
if the latter is not available for any reason. A promising
possibility to facilitate health behavior among hay fever
sufferers is the implementation of educational interven-
tions aimed at helping individuals evaluate their existing
hay fever management routines and obtain additional
information on allergy management. Educational in-
terventions to improve allergy management should
focus on increasing awareness of health-related risks
associated with allergic diseases for individuals with
unappropriated allergy management. If such interven-
tions are accompanied by the provision of informa-
tion on various instrumental and psychological coping
strategies to increase the perceived self-efficacy of
allergic individuals, an even stronger effect on the
desired target behavior might be achieved.
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